Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients | Zendy

Fatina I. Fadel | Zendy; Hafez M Bazraa | Zendy; Safaa Abdelrahman | Zendy; Mohamed Shouman | Zendy; Marwa Khaled Sayed | Zendy; Doaa M. Salah | Zendy; Aliaa Ahmed Wahby | Zendy; Heba F Elgebaly | Zendy

Open Access

Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients

Author(s) -

Fatina I. Fadel,

Hafez M Bazraa,

Safaa Abdelrahman,

Mohamed Shouman,

Marwa Khaled Sayed,

Doaa M. Salah,

Aliaa Ahmed Wahby,

Heba F Elgebaly

Publication year - 2017

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2017.032

Subject(s) - medicine , endothelial dysfunction , brachial artery , hemodialysis , end stage renal disease , disease , renal transplant , cardiology , transplantation , gastroenterology , blood pressure

Renal transplantation (RTx) is the treatment of choice for paediatric end-stage renal disease (ESRD). A major cause of morbidity and mortality after RTx is cardiovascular disease. Independent predictors of cardiovascular events were shown to constitute an endothelial dysfunction (ED). This study aims to evaluate Visfatin serum level in comparison to brachial artery flow-mediated dilatation (FMD) as a marker of endothelial dysfunction in paediatric RTx recipients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research